Zacks Investment ResearchWed, 01 Jul 2026 17:01:04 GMTResMed (RMD) Upgraded to Buy: Here's WhyRMD+4.24%
Zacks Investment ResearchWed, 01 Jul 2026 14:55:13 GMTWall Street Analysts Think ResMed (RMD) Could Surge 28.21%: Read This Before Placing a BetRMD+4.24%
Seeking AlphaMon, 29 Jun 2026 21:18:40 GMTResMed: Fear-Driven Selloff Creates A Compelling Margin Of Safety Entry PointRMD+4.24%
BenzingaWed, 17 Jun 2026 13:13:10 GMTThis ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For WednesdayRMD+4.24%
Zacks Investment ResearchTue, 16 Jun 2026 14:46:05 GMTWhy ResMed (RMD) is a Top Growth Stock for the Long-TermRMD+4.24%
Zacks Investment ResearchTue, 09 Jun 2026 13:55:21 GMTIs This the Right Time to Retain Resmed Stock in Your Portfolio?RMD+4.24%
Seeking AlphaWed, 03 Jun 2026 08:04:20 GMTResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks TranscriptRMD+4.24%
Zacks Investment ResearchTue, 26 May 2026 14:46:12 GMTResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?RMD+4.24%
24/7 Wall StreetMon, 25 May 2026 03:21:12 GMTThe Hidden 401(k) Tax Bomb That Hits a $1.3 Million Saver With $19,800 in Their First RMD YearRMD+4.24%
24/7 Wall StreetFri, 22 May 2026 17:47:23 GMTThe In Plan Roth 401(k) Conversion That Saves a $400,000 Earner $58,000 in Future RMD TaxesRMD+4.24%
Zacks Investment ResearchWed, 20 May 2026 19:40:31 GMTIs the Options Market Predicting a Spike in ResMed Stock?RMD+4.24%
FXEmpireWed, 13 May 2026 00:00:25 GMTMiners Cushion ASX 200 Slide as Weak NAB Confidence and Bearish Renko Signal Downside RiskRMD+4.24%XEM-9.70%RIO+1.15%
Zacks Investment ResearchTue, 05 May 2026 14:45:43 GMTHere's Why ResMed (RMD) is a Strong Growth StockRMD+4.24%
Zacks Investment ResearchFri, 01 May 2026 13:05:31 GMTRMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins RiseRMD+4.24%
Seeking AlphaFri, 01 May 2026 00:21:35 GMTResMed Inc. (RMD) Q3 2026 Earnings Call TranscriptRMD+4.24%
Zacks Investment ResearchThu, 30 Apr 2026 22:30:27 GMTResMed (RMD) Reports Q3 Earnings: What Key Metrics Have to SayRMD+4.24%
Zacks Investment ResearchThu, 30 Apr 2026 22:30:21 GMTResMed (RMD) Surpasses Q3 Earnings and Revenue EstimatesRMD+4.24%
Zacks Investment ResearchWed, 29 Apr 2026 14:15:33 GMTWall Street's Insights Into Key Metrics Ahead of ResMed (RMD) Q3 EarningsRMD+4.24%
Zacks Investment ResearchThu, 23 Apr 2026 15:05:12 GMTResMed (RMD) Reports Next Week: Wall Street Expects Earnings GrowthRMD+4.24%
